This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

29 November - 9 December, 2021
Delivered in a 100% Digital Format as a Free-to-Attend Webinar Series

David Ausländer, PhD
Investigator III, NIBR Biologics Center at Novartis Pharma AG


David Ausländer works as investigator at the NIBR Biologics Center in the Cell Line Screening & Develoment unit at Novartis Pharma AG in Basel (Switzerland) and is responsible for the innovation portfolio covering all aspects of mammalian expression and cell engineering. Before, he worked as research scientist at ETH Zürich with the focus on technology developments in the fields of mammalian cell engineering and Synthetic Biology. He received his doctorate from ETH Zürich in 2014, where he developed synthetic gene circuits for mammalian cells with applications in biopharmaceutical manufacturing and cell-based therapies.

Agenda Sessions

  • Generation of Improved Host Cell Lines for Biomanufacturing using Vector & Cell Line Engineering Technologies